Article
Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.
PloS one - 1 Jan 2017
Kormann Michael S D, Dewerth Alexander, Eichner Felizitas, Baskaran Praveen, Hector Andreas, Regamey Nicolas, Hartl Dominik, Handgretinger Rupert, Antony Justin S
Abstract excerpt
Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent and caused by mutations in the CFTR gene. However, the disease severity is immensely variable even among patients with similar CFTR mutations due to the possible effect of 'modifier genes'. To identify genetic modifiers, we applied RNA-seq based transcriptomic analyses in CF patients with a mild and severe lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
